Multiple Sclerosis Abdulelah Nuqali Intern. DemyelinationCNSAquired Multiple Sclerosis Optic...

21
Multiple Sclerosis Abdulelah Nuqali Intern

Transcript of Multiple Sclerosis Abdulelah Nuqali Intern. DemyelinationCNSAquired Multiple Sclerosis Optic...

Page 1: Multiple Sclerosis Abdulelah Nuqali Intern. DemyelinationCNSAquired Multiple Sclerosis Optic neuritis Acute Disseminated Encephalomyelitis Hereditary.

Multiple Sclerosis

Abdulelah NuqaliIntern

Page 2: Multiple Sclerosis Abdulelah Nuqali Intern. DemyelinationCNSAquired Multiple Sclerosis Optic neuritis Acute Disseminated Encephalomyelitis Hereditary.
Page 3: Multiple Sclerosis Abdulelah Nuqali Intern. DemyelinationCNSAquired Multiple Sclerosis Optic neuritis Acute Disseminated Encephalomyelitis Hereditary.
Page 4: Multiple Sclerosis Abdulelah Nuqali Intern. DemyelinationCNSAquired Multiple Sclerosis Optic neuritis Acute Disseminated Encephalomyelitis Hereditary.

What is Multiple Sclerosis?

• Multiple Sclerosis (MS) is an acquired inflammatory demyelinating disease of the CNS (brain and spinal cord).

Page 5: Multiple Sclerosis Abdulelah Nuqali Intern. DemyelinationCNSAquired Multiple Sclerosis Optic neuritis Acute Disseminated Encephalomyelitis Hereditary.

MS is a Demyelinating Disease

Myelin – provides insulation to nerve processes (axons)

Blood vessel

Blood vessel

Blood vessel

Inflammation

Inflammation

Inflammation

Myelin – provides insulation to nerve processes (axons)

Blood vessel

Blood vessel

Blood vessel

Blood vessel

Blood vessel

Blood vessel

Inflammation

Inflammation

Inflammation

Inflammation

Inflammation

Inflammation

Page 6: Multiple Sclerosis Abdulelah Nuqali Intern. DemyelinationCNSAquired Multiple Sclerosis Optic neuritis Acute Disseminated Encephalomyelitis Hereditary.

How Common is MS and Who Gets It?

• 8,000 – 10,000 new cases are diagnosed annually• Affects nearly 500,000 individuals in the U.S.• Occurs most frequently between ages 25 - 35• Affects women 2 to 3 times as often as men• More frequent in populations native to areas further

away from the equator• Prevalence of MS in KSA is 4-8 cases per 100,000

Page 7: Multiple Sclerosis Abdulelah Nuqali Intern. DemyelinationCNSAquired Multiple Sclerosis Optic neuritis Acute Disseminated Encephalomyelitis Hereditary.

What Causes MS?

• Unknown• Genetics• Environmental factors

Page 8: Multiple Sclerosis Abdulelah Nuqali Intern. DemyelinationCNSAquired Multiple Sclerosis Optic neuritis Acute Disseminated Encephalomyelitis Hereditary.

Not Everyone with a Genetic Risk Will Develop MS – Why?

• Risk is modified by Environmental factors– Sunlight– Diet (e.g., vitamin D)– Other lifetime experiences (infections?)

Page 9: Multiple Sclerosis Abdulelah Nuqali Intern. DemyelinationCNSAquired Multiple Sclerosis Optic neuritis Acute Disseminated Encephalomyelitis Hereditary.

Initial Presentation of MS

Incidence (%)

Optic nerve inflammation 14–29

Poor balance (ataxia) 2–18

Dizziness (vertigo) 2–9

Weakness 10–40

Double visions (diplopia) 8–18

Bladder, bowel dysfunction 0–14

Pain 21–40

Sensory loss 13–39

Page 10: Multiple Sclerosis Abdulelah Nuqali Intern. DemyelinationCNSAquired Multiple Sclerosis Optic neuritis Acute Disseminated Encephalomyelitis Hereditary.

Other Common Symptoms of MS

•Fatigue•Spasticity•Sexual dysfunction•Cognitive impairment

–Generally occurs later in the disease

Page 11: Multiple Sclerosis Abdulelah Nuqali Intern. DemyelinationCNSAquired Multiple Sclerosis Optic neuritis Acute Disseminated Encephalomyelitis Hereditary.

Multiple Sclerosis Clinical SubtypesMultiple Sclerosis Clinical Subtypes

Lublin FD et al. Neurology. 1996;46:907-911.

Relapsing-remitting

Primary-progressive

Dis

abili

ty

Time

Time

Dis

abili

tySecondary-progressive

Progressive-relapsing

Time

Time

Dis

abili

tyD

isab

ility

Page 12: Multiple Sclerosis Abdulelah Nuqali Intern. DemyelinationCNSAquired Multiple Sclerosis Optic neuritis Acute Disseminated Encephalomyelitis Hereditary.

How Is MS Diagnosed?

• At least two episodes of symptoms – Occur at different points in time (DIT)– Result from involvement of different areas of

the central nervous system (DIS)

• Absence of other treatable causes for the symptoms

• Results of neurological testing

Page 13: Multiple Sclerosis Abdulelah Nuqali Intern. DemyelinationCNSAquired Multiple Sclerosis Optic neuritis Acute Disseminated Encephalomyelitis Hereditary.

Examples of MS Onset• Case 1: 26 year old woman

– Decreased vision in the right eye in 9/05– Left leg numbness in 1/06– Right face numbness, right arm and leg weakness in 4/06 – Left leg weakness in 8/06

• Case 2: 45 year old man– Left arm weakness in 2/93– Numbness below the waist in 4/07

Page 14: Multiple Sclerosis Abdulelah Nuqali Intern. DemyelinationCNSAquired Multiple Sclerosis Optic neuritis Acute Disseminated Encephalomyelitis Hereditary.

How Is MS Diagnosed?

Magnetic resonance imaging (MRI)CSF :• slight mononuclear pleocytosis or elevated in

protein• Increase IgG ( elevated IgG index OR the

presence of oligoclonal IgG bands )Visual evoked potentials

Page 15: Multiple Sclerosis Abdulelah Nuqali Intern. DemyelinationCNSAquired Multiple Sclerosis Optic neuritis Acute Disseminated Encephalomyelitis Hereditary.

Magnetic Resonance Imaging in MS

Spinal cordOptic nerve

Brain

Spinal cordSpinal cordOptic nerveOptic nerve

BrainBrain

Page 16: Multiple Sclerosis Abdulelah Nuqali Intern. DemyelinationCNSAquired Multiple Sclerosis Optic neuritis Acute Disseminated Encephalomyelitis Hereditary.

The 2010 McDonald Criteria for Diagnosis of MS

Page 17: Multiple Sclerosis Abdulelah Nuqali Intern. DemyelinationCNSAquired Multiple Sclerosis Optic neuritis Acute Disseminated Encephalomyelitis Hereditary.

How is MS Treated and Managed?

• Drug therapy– Treat new attacks (exacerbations)– Prevent the occurrence of future attacks– Slow or prevent disease progression– Treat the chronic symptoms of the disease

• Physical therapy• Psychosocial support

Page 18: Multiple Sclerosis Abdulelah Nuqali Intern. DemyelinationCNSAquired Multiple Sclerosis Optic neuritis Acute Disseminated Encephalomyelitis Hereditary.

Treatment of New MS Exacerbations

• Drug therapy– Corticosteroids– Intravenous immunoglobulin– Plasma exchange

• Physical therapy

Page 19: Multiple Sclerosis Abdulelah Nuqali Intern. DemyelinationCNSAquired Multiple Sclerosis Optic neuritis Acute Disseminated Encephalomyelitis Hereditary.

Prevention of Future Attacks and Disease Progression

• Immune modulating drugs– Beta-Interferon– Glatiramer acetate– Humanized monoclonal antibodies

• Immunosuppressant drugs– Anti-cancer agents

• Combination therapies

Page 20: Multiple Sclerosis Abdulelah Nuqali Intern. DemyelinationCNSAquired Multiple Sclerosis Optic neuritis Acute Disseminated Encephalomyelitis Hereditary.

Symptom Management – Examples

Symptom DrugSpasticity Baclofen

Trigeminal neuralgia & Dysethesias

Carbamazepine

Bladder Hyperactivity Anti- Cholinergics ( oxybutynin )

Urinary retention Cholinergics ( Bethanechol )

Fatigue SSRI ( fluoxetine )

Page 21: Multiple Sclerosis Abdulelah Nuqali Intern. DemyelinationCNSAquired Multiple Sclerosis Optic neuritis Acute Disseminated Encephalomyelitis Hereditary.

Summary• MS is a common inflammatory disease of the CNS

that affects females more frequently than males.• The cause of MS appears to be a combination of

genetic and environmental factors.• The symptoms of MS can be quite variable.• MRI is a sensitive test for making the diagnosis of

MS.• Treatments are available for reducing the number of

MS attacks and for slowing MS disease progression.